Company / Cash & Equivalents
Henry Schein Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$156.0M
FY2025
5-year range
$117.0M / $171.0M
FY2021-FY2025
Trend
+27.9%
vs FY2024
Sector context
#94 of 148
Health Care
What the data says
At $156M, Henry Schein's cash & equivalents ranks #94 of 148 in the Health Care sector. Cash & Equivalents has fluctuated over the past 9 years, ranging from $62M in FY2016 to $421M in FY2020.
Based on SEC 10-K filings.
$156M in FY2025 with a 5-year CAGR of -18.0%.
Declined from $171M to $156M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +10.1%
- 5-Year CAGR
- -18.0%
- 10-Year CAGR
- -
Sector benchmark
#94 of 148 in Health CareTop 64% of 148This company $156.0M Sector average $1.2B
▼
-86.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -18.0%, indicating a declining trend.
- In FY2025, cash & equivalents increased 27.9% year-over-year.
- Ranks #94 out of 148 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2020.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $156.0M | +27.9% |
| FY2024 | $122.0M | -28.7% |
| FY2023 | $171.0M | +46.2% |
| FY2022 | $117.0M | -0.8% |
| FY2021 | $118.0M | -72.0% |
| FY2020 | $421.2M | - |
| FY2019 | - | - |
| FY2018 | $80.2M | -54.1% |
| FY2017 | $174.7M | +180.0% |
| FY2016 | $62.4M | -13.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026